Cargando…
Advances in IKBKE as a potential target for cancer therapy
IKBKE (inhibitor of nuclear factor kappa‐B kinase subunit epsilon), a member of the nonclassical IKK family, plays an important role in the regulation of inflammatory reactions, activation and proliferation of immune cells, and metabolic diseases. Recent studies have demonstrated that IKBKE plays a...
Autores principales: | Yin, Min, Wang, Xin, Lu, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6943080/ https://www.ncbi.nlm.nih.gov/pubmed/31733040 http://dx.doi.org/10.1002/cam4.2678 |
Ejemplares similares
-
IKBKE Phosphorylation and Inhibition of FOXO3a: A Mechanism of IKBKE Oncogenic Function
por: Guo, Jian-Ping, et al.
Publicado: (2013) -
Retraction: IKBKE Phosphorylation and Inhibition of FOXO3a: A Mechanism of IKBKE Oncogenic Function
Publicado: (2023) -
The decreased expression of IKBKE in systemic lupus erythematosus
por: Zhu, Tingting, et al.
Publicado: (2020) -
Inhibition of CXCL12/CXCR4 axis as a potential targeted therapy of advanced gastric carcinoma
por: Xue, Li‐Jun, et al.
Publicado: (2017) -
Lactate dehydrogenase A: A key player in carcinogenesis and potential target in cancer therapy
por: Feng, Yangbo, et al.
Publicado: (2018)